11 Best High Volume Penny Stocks to Buy Now
After a prolonged period where mega-cap stocks dominated returns, smaller and more speculative names are starting to see renewed trading activity.
Humacyte Inc. (HUMA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Antipodes Partners Jacob Mitchell | 5,723,750 | $3,472,599 | +49040% | 0.07% |
| 2. | Fisher Asset Management Ken Fisher | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.54 | 6,493 | $9,999.22 | 22,018 | 2025-04-14 | Filing | |
| $1.53 | 20,000 | $30,600.00 | 40,600 | 2025-04-10 | Filing | |
| $1.55 | 7,500 | $11,625.00 | 7,500 | 2025-04-10 | Filing | |
| $1.32 | 50,000 | $66,000.00 | 91,207 | 2025-04-08 | Filing | |
| $1.29 | 6,000 | $7,740.00 | 8,400 | 2025-04-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.58 | 591,685 | $934,862.30 | 0 | 2025-08-20 | Filing | |
| $1.63 | 1,100,000 | $1,793,000.00 | 591,685 | 2025-08-19 | Filing | |
| $1.83 | 549,360 | $1,005,328.80 | 1,691,685 | 2025-08-18 | Filing | |
| $1.58 | 591,685 | $934,862.30 | 0 | 2025-08-20 | Filing | |
| $1.63 | 1,100,000 | $1,793,000.00 | 591,685 | 2025-08-19 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,158,162 | $4,345,004 | 0% | |
| 2. | 2,782,070 | $1,688,716 | 0% | |
| 3. | 1,417,825 | $860,620 | 0% | |
| 4. | 1,011,029 | $613,695 | 0% | |
| 5. | 864,463 | $524,470 | 0% |
News See All
Humacyte (HUMA): Benchmark Remains Bullish on Stock
In mid-November, Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte, Inc. (NASDAQ:HUMA) stock and set a price target of $11. Humacyte, Inc.
11 Best Micro-Cap Stocks to Invest in According to Analysts
Micro-cap companies, generally referring to publicly traded businesses with less than $300 million in market capitalization, are among the most volatile and high-risk investments in the stock market.
Humacyte, Inc. (NASDAQ:HUMA) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Humacyte, Inc. (NASDAQ:HUMA) Q2 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Second Quarter 2025 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Humacyte, Inc. (NASDAQ:HUMA) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen and welcome to the Humacyte's First Quarter Results Conference Call. Currently, all participants are in a listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Humacyte Fourth Quarter Results Conference Call. Currently all participants are in listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Third Quarter 2024 Results Conference Call. Currently, all participants are in a listen-only mode.
Humacyte, Inc. (NASDAQ:HUMA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Humacyte's Second Quarter Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Humacyte, Inc. (NASDAQ:HUMA) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte First Quarter 2024 Results Conference Call. Currently all participants are in a listen-only mode.
Hedge Fund Resource Center